Christian Nash Zebedeo1, Chad Davis1, Cecelia Peña2, Kok Wei Ng1, Jean C Pfau3. 1. Department of Biological Sciences, Idaho State University, Pocatello, ID, USA. 2. Northwest Nazarene University, Nampa, ID, USA. 3. Department of Biological Sciences, Idaho State University, Pocatello, ID, USA. Electronic address: pfaujean@isu.edu.
Abstract
BACKGROUND: Erionite has similar chemical and physical properties to amphibole asbestos, which induces autoantibodies in mice. Current exposures are occurring in North Dakota due to the use of erionite-contaminated gravel. While erionite is known to cause mesothelioma and other diseases associated with asbestos, there is little known about its effects on the immune system. OBJECTIVES: We performed this study to determine whether erionite evokes autoimmune reactions in mice. METHODS: Bone marrow derived macrophages (BMDM) were used to measure toxicity induced by erionite. Cytokine production by BMDM and splenocytes of C57BL/6 mice was examined by bead arrays and ELISA following exposure to erionite, amphiboles and chrysotile. Wild type C57BL/6 mice were exposed to saline, erionite, amphibole asbestos (Libby 6-Mix) or chrysotile through intratracheal instillations at equal mass (60μg/mouse). Seven months after exposure, sera were examined for anti-nuclear antibodies (ANA) and IL-17. Immunohistochemistry was used to detect immune complex deposition in the kidneys. RESULTS: Erionite and tremolite caused increased cytokine production belonging to the TH17 profile including IL-17, IL-6, TGF-β, and TNF-α. The frequency of ANA was increased in mice treated with erionite or amphibole compared to saline-treated mice. IL-17 and TNF-α were elevated in the sera of mice treated with erionite. The frequency of immune complex deposition in the kidneys increased from 33% in saline-treated mice to 90% with erionite. CONCLUSIONS: These data demonstrate that both erionite and amphibole asbestos induce autoimmune responses in mice, suggesting a potential for adverse effects in exposed communities.
BACKGROUND:Erionite has similar chemical and physical properties to amphibole asbestos, which induces autoantibodies in mice. Current exposures are occurring in North Dakota due to the use of erionite-contaminated gravel. While erionite is known to cause mesothelioma and other diseases associated with asbestos, there is little known about its effects on the immune system. OBJECTIVES: We performed this study to determine whether erionite evokes autoimmune reactions in mice. METHODS: Bone marrow derived macrophages (BMDM) were used to measure toxicity induced by erionite. Cytokine production by BMDM and splenocytes of C57BL/6 mice was examined by bead arrays and ELISA following exposure to erionite, amphiboles and chrysotile. Wild type C57BL/6 mice were exposed to saline, erionite, amphibole asbestos (Libby 6-Mix) or chrysotile through intratracheal instillations at equal mass (60μg/mouse). Seven months after exposure, sera were examined for anti-nuclear antibodies (ANA) and IL-17. Immunohistochemistry was used to detect immune complex deposition in the kidneys. RESULTS:Erionite and tremolite caused increased cytokine production belonging to the TH17 profile including IL-17, IL-6, TGF-β, and TNF-α. The frequency of ANA was increased in mice treated with erionite or amphibole compared to saline-treated mice. IL-17 and TNF-α were elevated in the sera of mice treated with erionite. The frequency of immune complex deposition in the kidneys increased from 33% in saline-treated mice to 90% with erionite. CONCLUSIONS: These data demonstrate that both erionite and amphibole asbestos induce autoimmune responses in mice, suggesting a potential for adverse effects in exposed communities.
Authors: S Kotake; N Udagawa; N Takahashi; K Matsuzaki; K Itoh; S Ishiyama; S Saito; K Inoue; N Kamatani; M T Gillespie; T J Martin; T Suda Journal: J Clin Invest Date: 1999-05 Impact factor: 14.808
Authors: Nancy Agmon-Levin; Jan Damoiseaux; Cees Kallenberg; Ulrich Sack; Torsten Witte; Manfred Herold; Xavier Bossuyt; Lucille Musset; Ricard Cervera; Aresio Plaza-Lopez; Carlos Dias; Maria José Sousa; Antonella Radice; Catharina Eriksson; Olof Hultgren; Markku Viander; Munther Khamashta; Stephan Regenass; Luis Eduardo Coelho Andrade; Allan Wiik; Angela Tincani; Johan Rönnelid; Donald B Bloch; Marvin J Fritzler; Edward K L Chan; I Garcia-De La Torre; Konstantin N Konstantinov; Robert Lahita; Merlin Wilson; Olli Vainio; Nicole Fabien; Renato Alberto Sinico; Pierluigi Meroni; Yehuda Shoenfeld Journal: Ann Rheum Dis Date: 2013-10-14 Impact factor: 19.103
Authors: Michele Carbone; Y Izzettin Baris; Pietro Bertino; Brian Brass; Sabahattin Comertpay; A Umran Dogan; Giovanni Gaudino; Sandro Jube; Shreya Kanodia; Charles R Partridge; Harvey I Pass; Zeyana S Rivera; Ian Steele; Murat Tuncer; Steven Way; Haining Yang; Aubrey Miller Journal: Proc Natl Acad Sci U S A Date: 2011-07-25 Impact factor: 11.205
Authors: Glinda S Cooper; Kathleen M Gilbert; Eric L Greidinger; Judith A James; Jean C Pfau; Leslie Reinlib; Bruce C Richardson; Noel R Rose Journal: Environ Health Perspect Date: 2008-06 Impact factor: 9.031
Authors: E R Kisin; N Yanamala; D Rodin; A Menas; M Farcas; M Russo; S Guppi; T O Khaliullin; I Iavicoli; M Harper; A Star; V E Kagan; A A Shvedova Journal: Chemosphere Date: 2020-02-13 Impact factor: 7.086
Authors: Melissa A Bates; Christina Brandenberger; Ingeborg Langohr; Kazuyoshi Kumagai; Jack R Harkema; Andrij Holian; James J Pestka Journal: PLoS One Date: 2015-05-15 Impact factor: 3.240
Authors: Erin A Marshall; Kevin W Ng; Sonia H Y Kung; Emma M Conway; Victor D Martinez; Elizabeth C Halvorsen; David A Rowbotham; Emily A Vucic; Adam W Plumb; Daiana D Becker-Santos; Katey S S Enfield; Jennifer Y Kennett; Kevin L Bennewith; William W Lockwood; Stephen Lam; John C English; Ninan Abraham; Wan L Lam Journal: Mol Cancer Date: 2016-10-27 Impact factor: 27.401
Authors: Danielle J Carlin; Theodore C Larson; Jean C Pfau; Stephen H Gavett; Arti Shukla; Aubrey Miller; Ronald Hines Journal: Environ Health Perspect Date: 2015-08 Impact factor: 9.031